Clicky

Firebrick Pharma Limited(FRE)

Description: Firebrick Pharma Limited, a pharmaceutical company, develops and commercializes nasal spray treatment for the common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.


Keywords: Pharmaceutical Pharmacy Health Sciences Health Care Pharmacology Pharmaceutical Sciences Common Cold

Home Page: www.firebrickpharma.com

FRE Technical Analysis

NUVEEN INVESTMENT FUNDS INC
,

Phone: 1300 301 874


Officers

Name Title
Dr. Peter Laurence Molloy BSc, FAICD, MBA Founder, Exec. Chairman & CEO
Dr. Stephen Francis Goodall MASc, MBA Founder, COO & Exec. Director
Mr. Kavi Bekarma B.Sc., C.A. Chief Financial Officer
Dr. Simon Tucker Chief Scientific Officer
Ms. Robyn Branigan Head of Marketing
Prof. Peter Friedland Chief Medical Officer
Dr. Monique Baldwin Head of Regulatory Affairs
Ms. Kyla Garic Exec. Officer
Mr. Stephen Buckley Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 4.8027
Price-to-Sales TTM: 37.4846
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks